Expert explains the true costs of genetic testing

April 30, 2018, University of Toronto
Credit: University of Toronto

From 23 and Me and Ancestry DNA to research laboratories, genome sequencing has become widely available, but better understanding is needed on when it should be used and whether it should be covered by health plans, says a U of T health economics professor.

"On the one hand, it's great to see the public becoming more aware of options for genetic testing, but one downside is that people start to think of sequencing as a 'miracle ,' and that we should screen for every possible future disease no matter what the cost," says Wendy Ungar a professor of economics at the Dalla Lana School of Public Health's Institute of Health Policy, Management and Evaluation.

While the technology has advanced rapidly in recent years, policy has yet to keep up, she says. Some of the questions that need to be explored include whether all genetic testing should be covered by provincial or just a few.  Health-care systems like Ontario's have constrained budgets, so understanding what types or topics of genetic testing are cost-effective, is of major interest to the Ministry of Health and Long-term Care.

"We have to look at what makes sense in terms of value, and not simply whether a test costs $100 or even $1,000," says Ungar, who is also director of technology assessment at Sick Kids. "Is the test supported by scientific and economic evidence and will it truly help patients and clinicians in terms of treating or preventing disease – these are the types of questions we need to consider, not just the dollar amount."

Ungar is chair of Health Quality Ontario's Ontario Genetics Advisory Committee, also known as OGAC, where she and her colleagues are working to help the province and the ministry gain a better understanding of the value of different genetic tests and how or if they should be funded.

"We prioritize different topics of testing, such as carrier screening and non-invasive prenatal testing among others, and look at where there is the most need or demand," Ungar says. "Once these tests are prioritized, a health technology assessment and budget impact analysis are conducted, and the results are deliberated by the committee."

One topic of testing currently under deliberation is non-invasive prenatal screening.

"A pregnant woman actually has fetal DNA circulating in her bloodstream, so a simple blood draw can be analyzed to look at whether certain conditions may be present in the fetus," says Ungar.

Credit: University of Toronto

This test can identify chromosomal abnormalities related to trisomies such as Down syndrome and is currently only funded for women who are pregnant and considered high risk, such as those over the age of 40 or those with a family history of trisomies and other chromosomal abnormalities. The test, however, is not publicly funded for everyone. 

"Amniocentesis and chorionic villus sampling are other testing options available, but they pose a risk to the fetus and the pregnancy because they are much more invasive," Ungar says.

The committee also needs to consider the care pathway for prenatal care and how it might change if the decision was made to make the test available to all pregnant women.

 "At what stage of care should we offer the test – at the first ultrasound or as part of the first blood test? These are further questions we are taking into account as part of the review," Ungar says.

A funding recommendation for the test is expected to be posted to the HQO website for public feedback in May.

As for whether we should be more cautious about newer generations of such as , Ungar explains that patients can have several potentially pathogenic variants appear that are not related to the original reason for undergoing a genetic test.

These variants can show risks for breast cancer or colon cancer or even Huntington's disease. Once disclosed to the patient, they can trigger further costs to the health system as patients seek care from specialists to reduce their risks for such diseases.

 "It is not just a single test, a single result, or a single patient – there are a whole host of cascading effects that we need to consider, including effects on the patients themselves and their family members."

Explore further: ACOG issues recommendations on prenatal screening

Related Stories

ACOG issues recommendations on prenatal screening

March 4, 2016
(HealthDay)—Recommendations on screening for genetic disorders and fetal aneuploidy have been updated, according to two Practice Bulletins published online March 3 in Obstetrics & Gynecology.

Not all genetic tests should be publicly funded — here's why

February 1, 2018
New genetic technologies hold great promise in their potential to treat patients based on their individual genetic information. Advances in mapping the human genome mean the cost of doing a genetic test has fallen dramatically, ...

Majority of women prefer non-invasive testing for trisomy 21

December 15, 2017
(HealthDay)—The majority of both high-risk and intermediate-risk women prefer a non-invasive cell-free prenatal DNA screening (NIPT) as a secondary screening test for trisomy 21, according to a study published online Nov. ...

New technique could expand number of diseases detected by noninvasive prenatal testing

November 9, 2015
Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November ...

What genetic testing information to expect when you're expecting

February 2, 2018
Experts have recommended greater support and choice of information for pregnant women who decide to have genetic testing.

Non-invasive first trimester blood test reliably detects Down's syndrome

June 7, 2013
New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. ...

Recommended for you

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

New genome-editing strategy could lead to therapeutics

August 14, 2018
Researchers at UMass Medical School have developed a genome-editing strategy to correct disease-causing DNA mutations in mouse models of human genetic diseases, according to research published in the Aug. 18 edition of Nature ...

Study reveals broad 'genetic architectures' of traits and diseases

August 13, 2018
Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases. The new method provides a "big picture" ...

Genetic tools uncover cause of childhood seizure disorder missed by other methods

August 13, 2018
Early childhood seizures result from a rare disease that begin in the first months of life. Researchers at University of Utah Health have developed high-tech tools to uncover the genetic cause of the most difficult to diagnose ...

Researchers predict risk for common deadly diseases from millions of genetic variants

August 13, 2018
A research team at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School reports a new kind of genome analysis that could identify large fractions of the population who have ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.